Omega Therapeutics Inc (OMGA)
2.41
+0.03
(+1.26%)
USD |
NASDAQ |
May 17, 16:00
2.41
0.00 (0.00%)
After-Hours: 20:00
Omega Therapeutics Price to Book Value: 3.214 for May 17, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 17, 2024 | 3.214 |
| May 16, 2024 | 3.174 |
| May 15, 2024 | 3.041 |
| May 14, 2024 | 3.148 |
| May 13, 2024 | 3.141 |
| May 10, 2024 | 2.614 |
| May 09, 2024 | 2.894 |
| May 08, 2024 | 2.861 |
| May 07, 2024 | 2.874 |
| May 06, 2024 | 3.041 |
| May 03, 2024 | 3.441 |
| May 02, 2024 | 3.681 |
| May 01, 2024 | 3.308 |
| April 30, 2024 | 2.974 |
| April 29, 2024 | 3.054 |
| April 26, 2024 | 3.028 |
| April 25, 2024 | 3.134 |
| April 24, 2024 | 3.108 |
| April 23, 2024 | 3.121 |
| April 22, 2024 | 3.188 |
| April 19, 2024 | 3.201 |
| April 18, 2024 | 3.228 |
| April 17, 2024 | 3.408 |
| April 16, 2024 | 3.214 |
| April 15, 2024 | 3.354 |
| Date | Value |
|---|---|
| April 12, 2024 | 3.568 |
| April 11, 2024 | 3.948 |
| April 10, 2024 | 4.014 |
| April 09, 2024 | 4.028 |
| April 08, 2024 | 4.121 |
| April 05, 2024 | 3.934 |
| April 04, 2024 | 4.028 |
| April 03, 2024 | 3.848 |
| April 02, 2024 | 4.014 |
| April 01, 2024 | 4.268 |
| March 31, 2024 | |
| March 28, 2024 | 3.47 |
| March 27, 2024 | 3.375 |
| March 26, 2024 | 3.223 |
| March 25, 2024 | 3.242 |
| March 22, 2024 | 3.232 |
| March 21, 2024 | 3.394 |
| March 20, 2024 | 3.317 |
| March 19, 2024 | 3.260 |
| March 18, 2024 | 3.346 |
| March 15, 2024 | 3.441 |
| March 14, 2024 | 3.355 |
| March 13, 2024 | 3.716 |
| March 12, 2024 | 3.716 |
| March 11, 2024 | 3.850 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.5303
Minimum
Jun 01 2022
6.370
Maximum
Oct 29 2021
2.580
Average
2.610
Median
Price to Book Value Benchmarks
| Fate Therapeutics Inc | 1.042 |
| Macrogenics Inc | 2.576 |
| Ocular Therapeutix Inc | 2.342 |
| AnaptysBio Inc | 14.33 |
| Verrica Pharmaceuticals Inc | 243.89 |
Price to Book Value Related Metrics
| PS Ratio | 26.90 |
| Price | 2.41 |
| Earnings Yield | -68.88% |
| Market Cap | 132.92M |